2016 Regulatory Presentation: FSMA from a Foreign Government's Perspective
This presentation with Daniel Burgoyne, National Manager of Food Imports, Canadian Food Inspection Agency provided at the 2016 Regulatory Workshop covered exporting food to Canada as a shared responsibility for food safety and included imported food (Canadian context), current regulatory framework, and proposed "Safe Food for Canadians Regulations." CFIA shared its regulatory modernization, the Safe Foods for Canadians Act that was underway, its impact on the spice industry, and how the changes will facilitate compliance with the U.S. Food Safety Modernization Act (FSMA) as both countries move to modernize food safety.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
2019 Regulatory Presentation: The Interplay of Regulatory Policy and Control of Listeria Monocytogenes in Frozen Foods
This presentation was provided at the 2019 Regulatory Workshop. The presenter, Donna Garren, presented on Defining Ready-To-Eat Foods in the Absence of FDA Guidance, including RTE vs NRTE food recalls, Listeria Monocytogenes in frozen foods, and AFFI's strategy.
A Closer Look at FDA’s Guidance on Food Allergens Webinar
Presented on Friday, July 26, 2024. Undeclared allergens continue to be the leading cause of food recalls, and allergen control programs are commonly cited in 483s and Warning Letters. In the fall of 2023, the FDA released Chapter 11 of FDA’s Hazard Analysis and Risk-Based Preventive Controls for Human Food draft guidance, which addresses the FDA’s current thinking on how to develop and implement robust allergen preventive controls and cGMP programs. Additionally, in the fall of 2022, the FDA issued two guidance documents about food allergen labeling, including notable recommendations on allergen advisory labeling issues. In this webinar, Maile Gradison and Anneke Altieri will offer a deep dive into these guidance documents and share insight into the FDA’s expectations for allergen management programs, including label content and controls, supplier verification activities, advisory allergen labeling, and cGMPs.
